
Aeovian Pharmaceuticals
Developer of biotechnology therapies intended to address inflammatory and degenerative diseases. The company's platform utilizes small molecule therapeutics to target key cellular pathways involved in...
Valuation
$172M
Latest known
Share Price
N/A
Total Raised
$143.2M
Last Round
N/A